Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Obstet Gynecol ; 94(4): 600-7, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10511367

ABSTRACT

OBJECTIVE: To quantify the risk of cesarean delivery associated with elective induction of labor in nulliparous women at term. METHODS: We performed a cohort study on a major urban obstetric service that serves predominantly private obstetric practices. All term, nulliparous women with vertex, singleton gestations who labored during an 8-month period (n = 1561) were divided into three groups: spontaneous labor, elective induction, and medical induction. The risk of cesarean delivery in the induction groups was determined using stepwise logistic regression to control for potential confounding factors. RESULTS: Women experiencing spontaneous labor had a 7.8% cesarean delivery rate, whereas women undergoing elective labor induction had a 17.5% cesarean delivery rate (adjusted odds ratio [OR] 1.89; 95% confidence interval [CI] 1.12, 3.18) and women undergoing medically indicated labor induction had a 17.7% cesarean delivery rate (OR 1.69; 95% CI 1.13, 2.54). Other variables that remained significant risk factors for cesarean delivery in the model included: epidural placement at less than 4 cm dilatation (OR 4.66; 95% CI 2.25, 9.66), epidural placement after 4 cm dilatation (OR 2.18; 95% CI 1.06, 4.48), chorioamnionitis (OR 4.61; 95% CI 2.89, 7.35), birth weight greater than 4000 g (OR 2.59; 95% CI 1.69, 3.97), maternal body mass index greater than 26 kg/m2 (OR 2.36; 95% CI 1.61, 3.47), Asian race (OR 2.35; 95% CI 1.04, 5.34), and magnesium sulfate use (OR 2.18; 95% CI 1.04, 4.55). CONCLUSION: Elective induction of labor is associated with a significantly increased risk of cesarean delivery in nulliparous women. Avoiding labor induction in settings of unproved benefit may aid efforts to reduce the primary cesarean delivery rate.


Subject(s)
Cesarean Section/statistics & numerical data , Labor, Induced/statistics & numerical data , Adolescent , Adult , Body Mass Index , Cohort Studies , Female , Humans , Parity , Pregnancy , Risk Factors
2.
J Burn Care Rehabil ; 16(3 Pt 1): 253-7, 1995.
Article in English | MEDLINE | ID: mdl-7673304

ABSTRACT

Hydrofluoric acid burns are characterized by progressive tissue destruction and severe pain. Fluoride ion chelators, such as salts of calcium and magnesium, have been used to treat these burns. This study was designed to compare the efficacy of several treatment methods that involve the use of these salts. Standard hydrofluoric acid burns were produced on the shaved hindquarters of rats. After being rinsed with water, the chemical burns were treated by one of seven experimental methods. The progress of the chemical burn damage was observed for 1 week by measuring the surface areas of the burns. Calcium gluconate burn jelly, 20% calcium gluconate in water, and 50% aqueous dimethyl sulfoxide did not significantly slow the spread of the burn area. However, subcutaneous injections of calcium gluconate or magnesium sulfate and topical applications of calcium gluconate in a solution of dimethyl sulfoxide significantly slowed the progress of the burns during the first 24 hours and enhanced tissue recovery for the remainder of the observation period. These results indicate that subcutaneous injections of magnesium or calcium salts appear to be more effective than conventional topical applications in the treatment of hydrofluoric acid burns. More significantly, topically applied calcium gluconate combined with a penetration enhancer, such as dimethyl sulfoxide, is as effective as injection treatments in reducing damage caused by hydrofluoric acid.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Burns, Chemical/drug therapy , Calcium Gluconate/therapeutic use , Chelating Agents/therapeutic use , Dimethyl Sulfoxide/therapeutic use , Hydrofluoric Acid/adverse effects , Magnesium Sulfate/therapeutic use , Administration, Topical , Animals , Anti-Inflammatory Agents/administration & dosage , Burns, Chemical/pathology , Calcium Gluconate/administration & dosage , Chelating Agents/administration & dosage , Combined Modality Therapy , Dimethyl Sulfoxide/administration & dosage , Disease Models, Animal , Drug Therapy, Combination , Female , Injections, Subcutaneous , Magnesium Sulfate/administration & dosage , Rats , Rats, Sprague-Dawley , Skin/drug effects , Skin/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...